MX2021001763A - Clonacion de alto rendimiento de polinucleotidos inmunoreceptores bipartitas emparejados y aplicaciones de los mismos. - Google Patents
Clonacion de alto rendimiento de polinucleotidos inmunoreceptores bipartitas emparejados y aplicaciones de los mismos.Info
- Publication number
- MX2021001763A MX2021001763A MX2021001763A MX2021001763A MX2021001763A MX 2021001763 A MX2021001763 A MX 2021001763A MX 2021001763 A MX2021001763 A MX 2021001763A MX 2021001763 A MX2021001763 A MX 2021001763A MX 2021001763 A MX2021001763 A MX 2021001763A
- Authority
- MX
- Mexico
- Prior art keywords
- cloning
- bipartite
- immunoreceptor polynucleotides
- bipartite immunoreceptor
- paired
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title abstract 5
- 108091033319 polynucleotide Proteins 0.000 title abstract 5
- 239000002157 polynucleotide Substances 0.000 title abstract 5
- 238000010367 cloning Methods 0.000 title abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001111—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
- C12N2830/205—Vector systems having a special element relevant for transcription transcription of more than one cistron bidirectional
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862718227P | 2018-08-13 | 2018-08-13 | |
| US201862725842P | 2018-08-31 | 2018-08-31 | |
| US201862732898P | 2018-09-18 | 2018-09-18 | |
| US201962818355P | 2019-03-14 | 2019-03-14 | |
| US201962823831P | 2019-03-26 | 2019-03-26 | |
| PCT/US2019/046170 WO2020036875A1 (en) | 2018-08-13 | 2019-08-12 | High throughput cloning of paired bipartite immunoreceptor polynucleotides and applications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021001763A true MX2021001763A (es) | 2021-04-19 |
Family
ID=69525770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021001763A MX2021001763A (es) | 2018-08-13 | 2019-08-12 | Clonacion de alto rendimiento de polinucleotidos inmunoreceptores bipartitas emparejados y aplicaciones de los mismos. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11208457B2 (https=) |
| EP (1) | EP3837373B1 (https=) |
| JP (2) | JP7227374B2 (https=) |
| KR (2) | KR102543325B1 (https=) |
| CN (3) | CN116298309B (https=) |
| AU (1) | AU2019322834B2 (https=) |
| CA (1) | CA3108439A1 (https=) |
| IL (2) | IL294471B2 (https=) |
| MX (1) | MX2021001763A (https=) |
| SG (1) | SG11202101371TA (https=) |
| WO (1) | WO2020036875A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111712468A (zh) | 2017-12-22 | 2020-09-25 | 北卡罗莱纳州立大学 | 聚合物荧光团、包含其的组合物及制备和使用其的方法 |
| CN116298309B (zh) | 2018-08-13 | 2024-04-02 | 根路径基因组学公司 | 成对的二分免疫受体多核苷酸的高通量克隆及其应用 |
| US20210363543A1 (en) * | 2018-10-30 | 2021-11-25 | Nantbio, Inc. | Self Replicating RNA System |
| WO2020206238A2 (en) | 2019-04-05 | 2020-10-08 | Rootpath Genomics, Inc. | Compositions and methods for t-cell receptor gene assembly |
| WO2023091420A2 (en) * | 2021-11-16 | 2023-05-25 | TCR2 Therapeutics Inc. | Compositions and methods for t cell engineering |
| WO2023096890A1 (en) * | 2021-11-24 | 2023-06-01 | Rootpath Genomics, Inc. | Compositions and methods for polynucleotide assembly |
| CN115029341A (zh) * | 2022-05-23 | 2022-09-09 | 立凌生物制药(苏州)有限公司 | 一种快速克隆配对tcr序列检测方法及其应用 |
| WO2023179795A1 (zh) * | 2022-03-25 | 2023-09-28 | 立凌生物制药(苏州)有限公司 | 一种快速且简便地获得正确配对tcr的方法以及获得的tcr |
| CN114891779A (zh) * | 2022-03-31 | 2022-08-12 | 立凌生物制药(苏州)有限公司 | 一种克隆tcr序列的检测方法及其应用 |
| CN115725710A (zh) * | 2022-08-09 | 2023-03-03 | 立凌生物制药(苏州)有限公司 | 一种快速克隆肿瘤反应性tcr的方法及其应用 |
| WO2024077185A2 (en) * | 2022-10-06 | 2024-04-11 | The Regents Of The University Of California | Core-shell hydrogel particles with tunable porosity for digital nucleic acid assays |
| WO2024206549A2 (en) * | 2023-03-29 | 2024-10-03 | Cellicure, Inc. | Engineered immune cells and use thereof |
| CN116913417B (zh) * | 2023-04-07 | 2025-11-28 | 四川大学 | 一种dna结合小分子高通量筛选及表征方法 |
| JP2025071533A (ja) * | 2023-10-23 | 2025-05-08 | 美洛生物科技股▲ふん▼有限公司 | 新型誘導細胞質インビトロ転写様組成物およびその関連ワクチン医薬設計 |
| JP2025187393A (ja) * | 2024-06-13 | 2025-12-25 | 株式会社日立製作所 | Ｔ細胞受容体（ｔｃｒ）またはｂ細胞受容体（ｂｃｒ）の遺伝子検査方法および遺伝子検査キット |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US6905680B2 (en) | 1988-11-23 | 2005-06-14 | Genetics Institute, Inc. | Methods of treating HIV infected subjects |
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| GB9125768D0 (en) | 1991-12-04 | 1992-02-05 | Hale Geoffrey | Therapeutic method |
| US7175843B2 (en) | 1994-06-03 | 2007-02-13 | Genetics Institute, Llc | Methods for selectively stimulating proliferation of T cells |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| US6607878B2 (en) | 1997-10-06 | 2003-08-19 | Stratagene | Collections of uniquely tagged molecules |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US7572631B2 (en) | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| KR20030032922A (ko) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | 세포의 동시 자극 및 농축 |
| JP2004537313A (ja) | 2001-07-31 | 2004-12-16 | クローンテック ラボラトリーズ インク． | 細胞内のプロテアーゼ活性を検出する方法 |
| TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| MX2008000985A (es) | 2005-07-21 | 2008-04-07 | Abbott Lab | Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis. |
| US9029085B2 (en) | 2007-03-07 | 2015-05-12 | President And Fellows Of Harvard College | Assays and other reactions involving droplets |
| US8454906B2 (en) | 2007-07-24 | 2013-06-04 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
| EP3150724A1 (en) | 2008-12-19 | 2017-04-05 | President and Fellows of Harvard College | Particle-assisted nucleic acid sequencing |
| CA3285826A1 (en) | 2012-02-22 | 2026-03-02 | The Trustees Of The University Of Pennsylvania | Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer |
| EP3461910B1 (en) | 2012-04-19 | 2020-08-26 | Life Technologies Corporation | Nucleic acid amplification |
| US20150005199A1 (en) | 2012-08-14 | 2015-01-01 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| US20150005200A1 (en) | 2012-08-14 | 2015-01-01 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US20140378345A1 (en) | 2012-08-14 | 2014-12-25 | 10X Technologies, Inc. | Compositions and methods for sample processing |
| AU2013302756C1 (en) | 2012-08-14 | 2018-05-17 | 10X Genomics, Inc. | Microcapsule compositions and methods |
| US11203783B2 (en) * | 2013-11-21 | 2021-12-21 | Repertoire Genesis Incorporation | T cell receptor and B cell receptor repertoire analysis system, and use of same in treatment and diagnosis |
| NZ724320A (en) * | 2014-03-14 | 2022-05-27 | Adaptimmune Ltd | Tcr libraries |
| US11390921B2 (en) | 2014-04-01 | 2022-07-19 | Adaptive Biotechnologies Corporation | Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs) |
| US20150298091A1 (en) | 2014-04-21 | 2015-10-22 | President And Fellows Of Harvard College | Systems and methods for barcoding nucleic acids |
| EP3950944A1 (en) * | 2014-09-15 | 2022-02-09 | AbVitro LLC | High-throughput nucleotide library sequencing |
| CA2966201A1 (en) | 2014-10-29 | 2016-05-06 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
| BR112017008877A2 (pt) | 2014-10-29 | 2018-07-03 | 10X Genomics Inc | métodos e composições para sequenciamento de ácido nucleico-alvo |
| EP3277294B1 (en) | 2015-04-01 | 2024-05-15 | Adaptive Biotechnologies Corp. | Method of identifying human compatible t cell receptors specific for an antigenic target |
| AU2016253964B2 (en) * | 2015-04-27 | 2022-07-07 | Abvitro Llc | Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens |
| US9422547B1 (en) | 2015-06-09 | 2016-08-23 | Gigagen, Inc. | Recombinant fusion proteins and libraries from immune cell repertoires |
| GB201516275D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR Libraries |
| GB201516277D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR libraries |
| MX2018003534A (es) | 2015-09-25 | 2019-04-25 | Abvitro Llc | Proceso de alto rendimiento para identificacion de blanco de receptor de celula t de secuencias de receptor de celula t apareadas de manera natural. |
| KR20190006952A (ko) * | 2016-03-31 | 2019-01-21 | 라이언 티씨알 피티이. 리미티드 | 외인성 바이러스-특이적 t 세포 수용체 (tcr)를 발현하는 비-활성화된 t 세포 |
| WO2017177217A2 (en) * | 2016-04-08 | 2017-10-12 | Unum Therapeutics | Chimeric receptors and uses thereof in immune therapy |
| CN110520530A (zh) | 2016-10-18 | 2019-11-29 | 明尼苏达大学董事会 | 肿瘤浸润性淋巴细胞和治疗方法 |
| JP2020503883A (ja) | 2017-01-13 | 2020-02-06 | アジェナス インコーポレイテッド | Ｎｙ−ｅｓｏ−１に結合するｔ細胞受容体およびその使用方法 |
| US20200231974A1 (en) | 2017-07-18 | 2020-07-23 | Genovie Ab | A two-component vector library system for rapid assembly and diversification of full-length t-cell receptor open reading frames |
| WO2019126466A1 (en) | 2017-12-22 | 2019-06-27 | Rootpath Genomics, Inc. | Compositions and methods for barcoding |
| WO2019196088A1 (en) | 2018-04-13 | 2019-10-17 | Syz Cell Therapy Co. | Methods of obtaining tumor-specific t cell receptors |
| CA3099308A1 (en) | 2018-05-21 | 2019-11-28 | Compass Therapeutics Llc | Compositions and methods for enhancing the killing of target cells by nk cells |
| CN116298309B (zh) | 2018-08-13 | 2024-04-02 | 根路径基因组学公司 | 成对的二分免疫受体多核苷酸的高通量克隆及其应用 |
| WO2020206238A2 (en) | 2019-04-05 | 2020-10-08 | Rootpath Genomics, Inc. | Compositions and methods for t-cell receptor gene assembly |
| EP4061487A4 (en) | 2019-11-19 | 2023-12-20 | Rootpath Genomics, Inc. | COMPOSITIONS AND METHODS FOR IDENTIFYING T CELL RECEPTOR |
-
2019
- 2019-08-12 CN CN202310118607.9A patent/CN116298309B/zh active Active
- 2019-08-12 IL IL294471A patent/IL294471B2/en unknown
- 2019-08-12 CN CN201980067485.7A patent/CN112840031B/zh active Active
- 2019-08-12 KR KR1020217007322A patent/KR102543325B1/ko active Active
- 2019-08-12 CN CN202310093858.6A patent/CN116144706A/zh not_active Withdrawn
- 2019-08-12 KR KR1020237019408A patent/KR20230088518A/ko active Pending
- 2019-08-12 AU AU2019322834A patent/AU2019322834B2/en active Active
- 2019-08-12 JP JP2021532265A patent/JP7227374B2/ja active Active
- 2019-08-12 WO PCT/US2019/046170 patent/WO2020036875A1/en not_active Ceased
- 2019-08-12 IL IL280682A patent/IL280682B/en unknown
- 2019-08-12 MX MX2021001763A patent/MX2021001763A/es unknown
- 2019-08-12 CA CA3108439A patent/CA3108439A1/en active Pending
- 2019-08-12 SG SG11202101371TA patent/SG11202101371TA/en unknown
- 2019-08-12 EP EP19849196.1A patent/EP3837373B1/en active Active
-
2021
- 2021-02-11 US US17/173,705 patent/US11208457B2/en active Active
- 2021-11-17 US US17/528,550 patent/US12098181B2/en active Active
-
2023
- 2023-02-09 JP JP2023018149A patent/JP7475506B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL294471A (en) | 2022-09-01 |
| JP7475506B2 (ja) | 2024-04-26 |
| SG11202101371TA (en) | 2021-03-30 |
| US12098181B2 (en) | 2024-09-24 |
| IL294471B1 (en) | 2024-03-01 |
| US20220135641A1 (en) | 2022-05-05 |
| CN116144706A (zh) | 2023-05-23 |
| US20210171600A1 (en) | 2021-06-10 |
| IL294471B2 (en) | 2024-07-01 |
| AU2019322834B2 (en) | 2024-07-18 |
| KR20230088518A (ko) | 2023-06-19 |
| JP7227374B2 (ja) | 2023-02-21 |
| EP3837373A1 (en) | 2021-06-23 |
| CN116298309A (zh) | 2023-06-23 |
| KR102543325B1 (ko) | 2023-06-13 |
| US11208457B2 (en) | 2021-12-28 |
| KR20210057043A (ko) | 2021-05-20 |
| CN116298309B (zh) | 2024-04-02 |
| CN112840031B (zh) | 2023-03-24 |
| CN112840031A (zh) | 2021-05-25 |
| CA3108439A1 (en) | 2020-02-20 |
| JP2023058615A (ja) | 2023-04-25 |
| EP3837373B1 (en) | 2024-06-12 |
| WO2020036875A1 (en) | 2020-02-20 |
| JP2021534245A (ja) | 2021-12-09 |
| EP3837373A4 (en) | 2022-07-06 |
| IL280682A (en) | 2021-03-25 |
| AU2019322834A1 (en) | 2021-03-18 |
| IL280682B (en) | 2022-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021001763A (es) | Clonacion de alto rendimiento de polinucleotidos inmunoreceptores bipartitas emparejados y aplicaciones de los mismos. | |
| CO2021017741A2 (es) | Proteínas de fusión flt3l-fc y métodos de uso | |
| CO2018011804A2 (es) | Receptores quiméricos de flt3 y métodos de uso de los mismos | |
| CL2020002677A1 (es) | Receptores quiméricos y metodos de uso de los mismos(divisional de solicitud 2310-2019) | |
| EA201890423A1 (ru) | Слитые белки фактора ix, способы их получения и применения | |
| PH12018502645A1 (en) | Optimized mini-dystrophin genes and expression cassettes and their use | |
| CO2020013392A2 (es) | Receptores quiméricos de dll3 y métodos para su uso | |
| EA201992001A1 (ru) | Композиции и способы повышения экспрессии генов | |
| CY1125996T1 (el) | Ρυθμιστες της δραστικοτητας του συμπληρωματος | |
| MX385456B (es) | Anticuerpos cd123 y conjugados de los mismos. | |
| UY34781A (es) | Moduladores de la via del complemento y usos de los mismos | |
| MA44008A (fr) | 1,2,3-triazoles substitués utilisés comme modulateurs de nmda sélectifs de nr2b | |
| MX373149B (es) | Mezclas de pigmento/frita. | |
| DK4356969T3 (da) | Smeltede tricykliske pyridazinonforbindelser, der er nyttige til behandling af orthomyxovirusinfektioner | |
| CY1125552T1 (el) | Μεθοδος για την παρασκευη ουσιαστικα διαστερεομερικως καθαρου φωσφοροδιαμιδικου ολιγομερους, φωσφοροδιαμιδικου ολιγομερους που παρασκευαζεται με τετοια μεθοδο και φαρμακευτικη συνθεση αποτελουμενη απο τετοιο φωσφοροδιαμιδικο ολιγομερες | |
| CO2021000660A2 (es) | Receptores químericos de steap1 y métodos de uso de los mismos | |
| CY1124727T1 (el) | Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων | |
| DK3889166T3 (da) | Rekombinante virale vektorer, der indeholder mindre væsentlige prrsv-proteiner, og fremgangsmåder til fremstilling og anvendelse deraf | |
| MX2020003093A (es) | Anticuerpos anti-cd19 novedosos. | |
| WO2018221904A3 (ko) | 인간 성체 간세포 리프로그래밍 배지 조성물 | |
| IL291632A (en) | Lentiviral vector formulations | |
| SI4545100T1 (sl) | Stabilne, koncentrirane kompleksne raztopine radionuklidov | |
| MX2019000177A (es) | Formulaciones de anticuerpos. | |
| DK3853732T3 (da) | Rekonfigurerbare computerpods, der bruger optiske netværk | |
| BR112018012884A2 (pt) | novos anticorpos anti-mmp16 e métodos de uso |